Developed by MIRDC, the Omni Neuromodulation System is the first advanced device to enhance rTMS therapy, using innovative technologies to overcome conventional system limitations.
rTMS is a non-invasive technology using magnetic fields to generate weak currents that activate neural circuits for emotional regulation, offering an alternative or complementary option for patients unresponsive to traditional treatments.
The system stimulates deeper brain regions with accuracy and flexibility, avoiding cortical overstimulation by evenly distributing the magnetic field and using multiaxis switching to cover all neuronal orientations in the targeted gyri.
MIRDC collaborated with US company Nove to integrate intelligent algorithms that, together with multimodal composite pulse technology, adapt stimulation patterns to each patient’s neural profile, mimicking natural brain rhythms.
